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Abstract
Background: There has been significant effort in attempting to use health care data. However, laws that protect patients’ privacy
have restricted data use because health care data contain sensitive information. Thus, discussions on privacy laws now focus on
the active use of health care data beyond protection. However, current literature does not clarify the obstacles that make data
usage and deidentification processes difficult or elaborate on users’ needs for data linking from practical perspectives.
Objective: The objective of this study is to investigate (1) the current status of data use in each medical area, (2) institutional
efforts and difficulties in deidentification processes, and (3) users’ data linking needs.
Methods: We conducted a cross-sectional online survey. To recruit people who have used health care data, we publicized the
promotion campaign and sent official documents to an academic society encouraging participation in the online survey.
Results: In total, 128 participants responded to the online survey; 10 participants were excluded for either inconsistent responses
or lack of demand for health care data. Finally, 118 participants’ responses were analyzed. The majority of participants worked
in general hospitals or universities (62/118, 52.5% and 51/118, 43.2%, respectively, multiple-choice answers). More than half of
participants responded that they have a need for clinical data (82/118, 69.5%) and public data (76/118, 64.4%). Furthermore,
85.6% (101/118) of respondents conducted deidentification measures when using data, and they considered rigid social culture
as an obstacle for deidentification (28/101, 27.7%). In addition, they required data linking (98/118, 83.1%), and they noted
deregulation and data standardization to allow access to health care data linking (33/98, 33.7% and 38/98, 38.8%, respectively).
There were no significant differences in the proportion of responded data needs and linking in groups that used health care data
for either public purposes or commercial purposes.
Conclusions: This study provides a cross-sectional view from a practical, user-oriented perspective on the kinds of data users
want to utilize, efforts and difficulties in deidentification processes, and the needs for data linking. Most users want to use clinical
and public data, and most participants conduct deidentification processes and express a desire to conduct data linking. Our study
confirmed that they noted regulation as a primary obstacle whether their purpose is commercial or public. A legal system based
on both data utilization and data protection needs is required.
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Introduction
There has been considerable effort to use health care data [1,2],
and many countries have implemented regulations to protect
the privacy of patients and research subjects [3-5]. Owing to
the sensitivity of health care data, privacy protection laws have
limited its use [6]. Regulations that focus only on protecting
privacy are emerging as a major challenge in using health care
data [7-9].
Health care institutions and governments both generate a large
amount of heterogeneous data [10]. To use these decentralized
data, there have been dramatic increases in linking data from
diverse sources [11]. By using big data analytic approaches,
which leverage data drawn from multiple sources [12],
data-driven research has the potential for widespread positive
impact and global implications [13-16]. Efforts have been made
to use health care data for the following purposes: ensuring a
high level of evidence by using a large number of samples [17],
identifying risk factors [18], and improving diagnosis and
treatment standards [19].
However, in Korea, this use conflicts with the current regulations
because data linking requires the data be identified and shared
[20,21]. The privacy law of Korea is known as the strongest
principle in Asia [22-24]. Although most discussions about
privacy laws have centered on data protection, discussions about
the privacy law are now about the need to facilitate the
development of industries that utilize data beyond protection
[8]. However, there has been no mention of what makes data
usage and deidentification processes difficult or users’ needs
for data linking from a practical perspective.
The objective of this study is to investigate (1) the status of big
data utilization in different medical areas (general hospitals,
universities, industry, and academic society); (2) institutional
obstacles and efforts in deidentification processes, which is an
alternative approach for using health care data; and (3) users’
data linking needs.
Methods
Study Design and Data Collection
This study is designed to investigate the demand for health care
data, identify the difficulties in using health care data, and
develop improvements for using health care data from the
practical users’ perspective. For this, we conducted a
cross-sectional online survey. To recruit participants who use
health care data, we (1) publicized the survey promotion
campaign through social media (Facebook) and (2) sent official
documents to academic societies encouraging participation in
the online survey. Through the provided documents, anyone
who used health care data was able to participate in the
questionnaire (online open survey; see details in Multimedia
Appendix 1).
The online questionnaire was developed and distributed using
Office forms (Naver, Korea). This questionnaire could be
accessed from mobile phones and personal computers. To ensure
important questions were answered, seven mandatory items
were designated among the 17 questions. This function was
used to prevent participants from submitting responses without
checking the answers on mandatory items before submission.
However, the questionnaire did not verify data consistency. For
example, respondents who replied that they did not have a
demand for health care data could also select “clinical data” as
a response to the question asking about required data. To ensure
the validity of the questionnaire, the items on the questionnaire
were developed through 15 revisions in consultation with eight
experts over a period of approximately one month. The final
questionnaire consisted of 16 items within five parts. Each
screen contained one to eight questions; there were a total of
eight screens in the survey (on mobile and PC screens).
Ethical clearance was obtained from the Public Institutional
Review Board designated by The Korean Ministry of Health
and Welfare (number: 2018-2199-001) before data collection.
Participant Recruitment
We selected five academic societies (Korean Society of Medical
Informatics, Korean Society for Preventive Medicine, Korean
Cancer Association, Korea Society of Artificial Intelligence in
Medicine, and Korean Society of Epidemiology) that exhibit a
high demand for health care data or were recommended by
experts. Then, we encouraged participation in the survey by
sending an official letter requesting cooperation for online
surveys to the secretariat of each academic society.
A web link to access the survey was provided to interested
respondents. Respondents were required to provide consent
through this link. To receive consent from respondents, the first
screen of the online questionnaire included the background,
purpose, and duration of the research, as well as a description
of the disadvantages or limitations. After respondents approved
this introduction, the link led to the anonymous online
questionnaire. As an incentive for participation, they were
offered coffee gift vouchers by submitting their cell phone
numbers. To transfer the coffee vouchers and exclude duplicate
responses, informed consent to collect cell phone numbers was
received separately. The cross-sectional online survey was
conducted between October 5 and 19, 2018.
By the end of the survey period, 128 participants responded to
the online survey. Responses that were contradictory (n=2) or
did not exhibit a demand for health care data (n=8) were
excluded; therefore, a total of 118 participants were included
in the analysis. The overall eligible population of subjects was
unknown because the online survey was sent to the five
academic societies and was advertised through a social media
promotion.
J Med Internet Res 2019 | vol. 21 | iss. 8 | e14126 | p. 2https://www.jmir.org/2019/8/e14126/
(page number not for citation purposes)
Kim et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Among the responses (N=118), quality improvement of welfare
services and research promotion were considered to be public
purposes (81/115, 70.4%) and industrial development and profit
generation were classified as commercial purposes (34/115,
29.6%); this classification excludes other minor purposes (n=3).
Questionnaire Items
The survey items were categorized into five parts. The first part
included items that investigated the work experience and basic
information of participants. The second part inquired about the
type of data participants wanted. The third part related to
obstacles and improvement suggestions for data use. The fourth
part investigated the identification process, and the last part
investigated data linking (details in Multimedia Appendix 2).
Statistical Analysis
Analyses were conducted using R (version 3.5.1) and Microsoft
Excel (version 2016). Descriptive statistics for proportions of
respondents, work profiles (eg, age, work experience, expertise
area, working institution), and responses regarding data demand,
data linking, and deidentification were explored.
For categorical variables, such as data needs, obstacles, and
improvement suggestions, chi-square tests were performed to
show these reponses were different between participants using
data for public purposes and those using data for commercial
purposes. We conducted chi-square tests with one section as
the response to specific questions, such as obstacles to using
health care data. Chi-square tests could not be performed for
responses to questions that allowed participants to choose more
than one answer (multiple response questions), such as data
needs, because the responses were not independent. For
questions that could have multiple responses, post hoc chi-square
tests were performed (Multimedia Appendices 3 and 4). Post
hoc pairwise chi-square tests involved testing each value of the
nominal variable versus the sum of all others. After applying
the same principle of chi-square to get the P value for each
comparison, we then used Bonferroni correction to counteract
the problem of type I error that occurs when multiple
comparisons are made.
Results
Overall Population
The majority of online survey participants worked in a general
hospital (62/118, 52.5%; multiple response question) or
university (51/118, 43.2%; multiple response). Most participants
were in the field of research (84/118, 71.2%), in their thirties
(56/118, 47.5%), and had work experience between 1 and 5
years (56/118, 47.5%; Table 1).
Table 1. Profile of online survey respondents (N=118).
Respondents, n (%)Characteristics
Age (years)
21 (17.8)20-29
56 (47.5)30-39
34 (28.8)40-49
5 (4.2)50-59
2 (1.7)Other
Institution (multiple response question)
62 (52.5)General hospital
51 (43.2)University
15 (12.7)Industry
6 (5.1)Academic society
3 (2.6)Other
Expertise
84 (71.2)Research
18 (15.3)Data analysis
11 (9.3)Planning
5 (4.2)Device development
Expertise experience
9 (7.6)≥10 years
32 (27.1)5 years to <10 years
56 (47.5)1 year to <5 years
21 (17.8)<1 year
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Data Demand, Obstacles, and Improvement
Suggestions
More than half of participants replied that they had a need for
clinical data (82/118, 69.5%) and public data (76/118, 64.4%;
Table 2). Only the general hospital group selected clinical data
in a high proportion (56/62, 90.3%).
Participants reported that the most significant obstacles in trying
to use health care data were conflicts with the law (53/118,
44.9%) and data standardization (50/118, 42.4%). However,
the obstacles most frequently selected by each group were
different. Overall, the four groups of respondents by institution
(general hospital, university, industry, and academic society)
reported data standardization problems and legal conflicts as
the main challenges in using data.
Similarly, most participants indicated that legislation
improvement was required to overcome these data utilization
limitations (54/118, 45.8%), followed by the need for technical
measures for data standards (47/118, 39.8%). Overall,
participants suggested that law revision was the first priority of
improvement (Table 2).
There was no statistically significant difference in the percentage
of obstacles in groups that used health care data for either
commercial or public purposes (P=.38). However, both groups
indicated that data standardization and current laws function as
constraints of health care data use (Table 3).
Table 2. Data needs, obstacles, and developmental proposals for data utilization.
Total (N=118),
n (%)
Respondents, n (%)Characteristics
Other
(n=3)
Academic society
(n=6)
Industry
(n=15)
University
(n=51)
General hospital
(n=62)
Data needs (multiple response question)
82 (69.5)0 (0.0)5 (83.3)10 (66.7)29 (56.9)56 (90.3)Clinical data (collected during care process
in hospital)
76 (64.4)3 (100.0)5 (83.3)10 (66.7)32 (62.7)40 (64.5)Public data (managed by nation)
61 (51.7)0 (0.0)5 (83.3)3 (2.0)33 (64.7)38 (61.3)Research data (clinical research or trial data)
36 (30.5)1 (33.3)4 (66.7)8 (53.3)16 (31.4)17 (27.4)Life log data (patient generated health data)
28 (23.7)1 (33.3)2 (33.3)1 (6.7)18 (35.3)13 (21.0)Genetic data
Obstacle
53 (44.9)0 (0.0)2 (33.3)8 (53.3)19 (37.3)30 (48.4)Conflict of laws
50 (42.4)3 (100.0)3 (50.5)5 (33.3)23 (45.1)24 (38.7)Data standardization
9 (7.6)0 (0.0)1 (16.7)2 (13.3)4 (7.8)5 (8.1)Strict social recognition
2 (1.7)0 (0.0)0 (0.0)0 (0.0)1 (4.0)1 (1.6)Other
4 (3.4)0 (0.0)0 (0.0)0 (0.0)3 (5.9)2 (3.2)None
Improvement suggestion (multiple response question)
54 (45.8)2 (66.7)4 (66.7)7 (46.7)22 (43.1)29 (46.8)Law revision
47 (39.8)1 (33.3)3 (50.0)6 (40.0)23 (43.1)22 (35.5)Technical measures
16 (13.6)0 (0.0)0 (0.0)0 (0.0)7 (13.7)12 (19.4)Utilization support
22 (18.6)1 (33.3)1 (16.7)2 (13.3)11 (21.6)6 (9.7)Public consensus
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Table 3. Comparison of data demand, obstacles, and improvement suggestions between health care data use for commercial and public purposes
(N=115). Sample size excludes the n=3 for other minor purposes.
P valueChi-square (df)Respondents, n (%)Measures
Commercial purpose (n=34)Public purpose (n=81)
Not applicableNot applicableData needs (multiple response question)
28 (82.4)53 (65.4)Clinical data
23 (67.6)53 (65.4)Public data
16 (47.1)44 (54.3)Research data
18 (52.9)18 (22.2)Life log data
9 (26.5)17 (21.0)Genetic data
.382.9 (4)Obstacles
13 (38.2)38 (46.9)Conflict with laws
15 (44.1)35 (43.2)Data standardization
3 (8.8)6 (7.4)Strict social recognition
2 (5.9)1 (1.2)None
1 (2.9)1 (1.2)Other
Not applicableNot applicableImprovement (multiple response question)
15 (44.1)38 (46.9)Law revision
14 (41.2)33 (40.7)Technical method
1 (2.9)15 (18.5)Data utilization support
6 (17.6)14 (17.3)Public consensus
Deidentification
When using health care data, 101 participants responded that
they conduct deidentification measures (101/118, 85.6%). The
majority of participants reported that multiple deidentification
methods are used (64/101, 63.4%). The most common method
was pseudonymization (72/101, 71.3%), followed by masking
(57/101, 56.4%). Most respondents who conducted
deidentification considered privacy issues induced by rigid
social culture as the biggest problem for deidentification
(28/101, 27.7%), followed by the absence of clear criteria for
deidentification measures (24/101, 23.8%; Table 4).
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Table 4. Responses about the current state of data deidentification (N=118).
Respondents, n (%)Measures
Deidentify when using health care data (n=118)
101 (85.6)Yes
17 (14.4)No
Number of applied deidentification methods (n=101)
37 (31.4)1 method
33 (28.0)2 methods
18 (15.3)3 methods
4 (3.4)4 methods
9 (7.6)5 methods
Applied methods (n=101; multiple response question)
72 (71.3)Pseudonymization
57 (56.4)Masking
37 (36.6)Data reduction
30 (29.7)Data suppression
22 (21.8)Aggregation
Difficulties when deidentifying data (n=101)
28 (27.7)Strict social culture
24 (23.8)Absence of clear deidentification guideline
15 (14.9)Usefulness of deidentified data
14 (13.9)Lack of understanding of deidentification policy and technology
11 (10.9)Lack of relevant institution support
9 (8.9)Lack of deidentification measure for unstructured data
Data Linkage
The majority of participants answered that they require data
linking (98/118, 83.1%). The difference in the proportion of
respondents who wanted to use data linkage for public or
commercial purposes was not statistically significant (P=.64).
The 98 respondents who said that data linking was necessary
indicated that the purpose of linking data was to obtain
longitudinal data (62/98, 63.3%). In addition, deregulation and
data standardization comprised a large proportion of data linking
improvement suggestions (33/98, 33.7% and 38/98, 38.8%,
respectively). In the two items that investigated the reason for
data linkage and suggestions to facilitate data linking, the
proportion of responses in both the public purpose and
commercial purpose groups did not significantly differ (P=.16
and P=.47, respectively).
The groups that used data for public purposes responded that
health care data are to be used to develop health care policy
(41.8%, 28/81). On the other hand, the group that used data for
commercial purposes primarily responded that data was to be
used for the development of diagnostic technology (n=12; Table
5).
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Table 5. Demand for health care data linking.
P valueaChi-square (df)Participants, n (%)Measures
Total
N=118)
Other
(n=3)
Commercial
purpose
(n=34)
Public
purpose
(n=81)
.640.2 (1)Data linking
98 (83.1)1 (33.3)30 (88.2)67 (82.7)Required
20 (16.9)2 (66.7)4 (11.8)14 (17.3)Not required
.163.6 (2)Reason for data linking (n=98)
62 (63.3)0 (0.0)23 (76.7)39 (58.2)Obtain longitudinal data
20 (20.4)0 (0.0)5 (16.7)15 (22.4)Obtain larger number of subjects
16 (16.3)1 (100.0)2 (6.7)13 (19.4)Develop policy predicated on data
.472.5 (3)Suggestions for facilitating health care data linking (n=98)
33 (33.7)0 (0.0)11 (36.7)22 (32.8)Deregulation
38 (38.8)0 (0.0)10 (33.3)28 (41.8)Data standardization
20 (20.4)1 (100.0)8 (26.7)11 (16.4)Effective guidelines including procedure, responsibility,
and technology
7 (7.1)0 (0.0)1 (3.3)6 (9.0)Improvement of social recognition
.00318.8 (6)Usage details (n=98)
31 (31.6)1 (100.0)2 (6.7)28 (41.8)Development of health care policy
27 (27.6)0 (0.0)12 (40.0)15 (22.4)Development of diagnostic technology
16 (16.3)0 (0.0)4 (13.3)12 (17.9)Development of treatment modality
12 (12.2)0 (0.0)4 (13.3)8 (11.9)General research
8 (8.2)0 (0.0)6 (20.0)2 (3.0)Development of medical device
2 (2.0)0 (0.0)1 (3.3)1 (1.5)Development of new drug
2 (2.0)0 (0.0)1 (3.3)1 (1.5)Other
98 (100.0)1 (100.0)30 (100.0)67 (100.0)Subtotal
aPublic versus commercial.
Discussion
Principal Findings
The primary finding of this study was the clarification of each
health care area’s need for data. Most wanted to use clinical
data and public data, except for university respondents.
Considering the amount of stored data depending on the health
care field [25], it is understandable that clinical data are in high
demand.
Secondly, most participants who use health care data conduct
deidentification measures before data use. The majority of
deidentification measures are implemented using more than one
method. This survey was not able to distinguish between cases
in which deidentification was not conducted when required and
cases in which it was not conducted because the data was not
identifiable (whether due to the exclusion of personal
information or the lack of legal deidentification requirements).
Although it is not clear whether these respondents voluntarily
implemented deidentification measures or were obligated to do
so, it appears they consider health care data to be sensitive
information. Their use of multiple deidentification measures
may be considered proof of action to mitigate concerns about
privacy infringement. However, they pointed out that rigid social
culture acts as a primary obstacle in data deidentification.
Therefore, if we prove that privacy is guaranteed, we can achieve
social consensus and relieve sociocultural rigidity.
Lastly, the proportion of respondents who need to link data was
significantly larger than the proportion of respondents who do
not; these respondents indicated that deregulation and
standardization are necessary to facilitate data linkage. This
suggests that many of these respondents face difficulties due to
intensive regulation. Data users may experience legal conflicts
when they want to link data from external data sources. When
linking with external data, an identifier is required, which is
often personal information. If consent has been obtained for
other research purposes previously, this identifier can be used;
however, in big data analysis, there are limitations on obtained
consent [21]. Furthermore, for personal information to be
provided to third parties, they must obtain the consent of the
subjects (article 17, Personal Information Protection Act
[PIPA]). Practically, it has been burdensome for controllers to
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recontact individual subjects and obtain consent; thus, they may
be obstructed by law [26]. Data sharing and linkage are limited
by the PIPA [27].
In recent years, some countries have attempted to revise their
information protection legislation to prepare for the development
of a new information industry [28,29]. The United States has
enacted the Final Rule, a revision of the Common Rule, to
reduce the regulatory burden and create a new concept of broad
consent to enhance both the use and protection of data [4,30].
The European Union, by enacting the General Data Protection
Regulation, has strengthened data protection principles while
including principles such as the right to data portability [31].
In Japan, the concept of anonymizing processed information is
defined by law, and the use of personal information is being
promoted [32].
Yet, privacy remains an issue in countries that are trying to
implement centralized electronic health records (EHRs), such
as Canada. Centralized EHRs could have interoperability in
terms of data structure because the same data schema enables
data linking and communication. This would reduce the obstacle
for health care data use. However, in terms of comprehensive
use and communication of data, the privacy issue must be
handled for secondary use. Therefore, as long as privacy remains
an issue, there will also be a need for data linking. For example,
a study on a Canada-wide EHR system stated that privacy
systems should address the issues of deidentifying health care
data and privacy concerns [33,34]; skeptics have warned against
adopting a Canada-wide EHR system until then [35].
Furthermore, even with centralized EHRs, the privacy issue
will remain in situations of linking with privately collected data,
such as mobile data and data collected by wearable devices. In
a survey conducted in the United States to identify digital health
adoption and sentiments of consumers, results showed people
are rarely willing to provide personal health data to
pharmaceutical companies, research institutes, or information
technology companies [36].
Considering this global trend, the regulation of personal
information in Korea does not reflect these changes [37]. There
have been many studies on methods by which regulation can
be improved to reflect changes in secondary data usage;
however, to provide a basis for these legislative improvements,
there was a need for evidence to show that actual users
experienced these difficulties and needs for data linking.
The results of this study confirm that the use of health care data
conflicts with the law, which leads to the implication that
legislation should be revised to facilitate data utilization.
However, it should not simply be deregulated, but balanced
between protection and utilization, as is the case of major
countries. To improve this legal system, a survey of opinions
on the use of health care data also should be conducted on the
data supplier and beneficiary side (the general population). In
the United States, these surveys about digital health consumer’s
sentiments have been conducted, and most respondents remain
wary about sharing their health data with technology companies
[36]. Likewise, surveys on how the opinions of hospital’s data
managers differ from those of the users in our study should be
conducted to achieve a better social consensus and reconcile
the two areas of data utilization and protection.
Limitations
The respondents in this study were primarily involved in general
hospitals and universities, whereas the respondents in academia
and industry were few. Respondents affiliated with universities
are considered to hold concurrent positions in general hospitals.
In addition, we did not obtain significant information on the
characteristics of the entire population in the survey because
survey promotion was conducted through social network
services and the transmission of official documents. However,
considering the number of medical institutions in Korea (tertiary
hospitals or secondary hospitals) and the number of universities,
it is natural that many respondents belong to medical institutions
and universities. Although this may not directly represent the
opinion of the entire population in need of health care data, in
the absence of previous studies that directly investigate the
opinions of data users, this study has the advantage of
illuminating the present status of Korean data users’ perspectives
in a cross-sectional way.
In addition, to represent the overall opinion of the population,
it is necessary to select the population for each institution and
extract a sample using a stratified sampling method. We
examined the current circumstances of health care data use from
data users’ perspectives, but data managers and beneficiaries
should also be surveyed for policy development to ensure that
all parties are considered in bridging the gap between data
privacy and utilization.
Conclusion
This study provides a cross-sectional view from a practical
user-oriented perspective on the types of data users find
valuable, the efforts and obstacles that characterize
deidentification processes, and users’ needs for data linking.
Most respondents seek to use clinical and public data. Moreover,
most implement deidentification measures. We confirmed that
they want to link data but are limited by regulations regardless
of whether their purpose is commercial or public. A legal system
that is founded on both the utilization and protection of data is
necessary.
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